Boon Heon Tan
Managing Director, Biogen Idec, China
Tan Boon Heon is the Managing Director of Biogen Idec * China/Asia Expansion Markets, a region covering Greater China (China, Taiwan, Hong Kong), Korea and Southeast Asia. He is responsible for the commercial success, operational excellence and management of the teams in this region, and committed to introducing Biogen Idec’s pipeline of important specialty and rare disease drugs to these countries progressively.
Boon is an experienced pharmaceutical executive with a unique international experience spanning HQ, regional and country operations. He was previously with Merck, Sharp & Dohme (“MSD”), through its acquisition of Schering-Plough (“SP”), for more than 10 years. Boon’s former roles in MSD/SP included US Sales and Global Marketing, Asia-Pacific regional leadership, as well as various roles in China since 2008, including Head of Marketing, Regional General Manager of Shanghai, and Customer Solutions Director.
Prior to joining Biogen Idec in April 2012, Boon had a short stint with HR Consultancy firm Russell Reynolds as the head of the healthcare practice in China.
Boon started his professional career as a government official in the Singapore Economic Development Board, where he was last Assistant Head of the Life Sciences Division. In that role, Boon worked with other government agencies and companies to develop a world-class life sciences industry in Singapore.
A native Singaporean who is fluent in English and Mandarin Chinese, Boon holds Bachelors and Masters of Science in Engineering (Bioengineering) degrees from the University of Pennsylvania. He is a commissioned infantry officer in the Singapore Armed Forces and still holds a reserve appointment. Boon is married and lives in Shanghai with his wife.